Schrodinger, Inc. Insider Trading

SDGR

Last 12 months

Insiders sold $2.3M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$2.3M

0 buys · 17 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

None

in the last two years

Get an email when SDGR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 17	Karen Akinsanya See Remarks	Sold10b5-1 plan 2 parts	31,599	$29.37 average	928K	31%	Form 4
Jul 16	Rachit Jain EVP & CFO	Sold10b5-1 plan	875	$15.60	14K	1.7%	Form 4
Apr 16 – 17	Ramy Farid President & CEO	Sold10b5-1 plan 2 parts	86,000	$12.27 average	$1.06M	18%	Form 4
Apr 16	Rachit Jain EVP & CFO	Sold10b5-1 plan	844	$12.75	11K	1.6%	Form 4
Mar 5 – 6	Jenny Herman CAO	Sold10b5-1 plan 2 parts	1,383	$12.85 average	18K	3.8%	Form 4
Mar 5	Rachit Jain EVP & CFO	Sold10b5-1 plan	1,631	$12.90	21K	3.0%	Form 4
Mar 5	Yvonne Tran EVP, CLO & Cpo	Sold10b5-1 plan	1,094	$12.90	14K	2.0%	Form 4
Mar 5	Kenneth Patrick Lorton EVP, CTO & COO, Software	Sold10b5-1 plan	1,222	$12.90	16K	1.4%	Form 4
Mar 5	Ramy Farid President & CEO	Sold10b5-1 plan	3,661	$12.91	47K	1.1%	Form 4
Mar 5	Karen Akinsanya See Remarks	Sold10b5-1 plan	1,366	$12.90	18K	1.9%	Form 4
Mar 4	Robert Lorne Abel See Remarks	Sold10b5-1 plan	1,300	$12.81	17K	2.3%	Form 4
Mar 2	Ramy Farid President & CEO	Sold10b5-1 plan	5,560	$11.90	66K	1.6%	Form 4
Mar 2	Karen Akinsanya See Remarks	Sold10b5-1 plan	2,206	$11.99	26K	3.0%	Form 4
Feb 10	Jenny Herman CAO	Sold10b5-1 plan	752	$13.79	10K	2.7%	Form 4
Feb 10	Yvonne Tran EVP, CLO & Cpo	Sold10b5-1 plan	776	$13.80	11K	3.3%	Form 4
Feb 10	Kenneth Patrick Lorton EVP, CTO & COO, Software	Sold10b5-1 plan	925	$13.73	13K	1.7%	Form 4
Feb 9	Robert Lorne Abel See Remarks	Sold10b5-1 plan	1,230	$13.51	17K	6.0%	Form 4
Oct 16, 2025	Margaret Dugan Chief Medical Officer	Sold10b5-1 plan	1,395	$21.07	29K	5.4%	Form 4
Apr 14, 2025	Karen Akinsanya President of R&D, Therapeutics	Sold10b5-1 plan 3 parts	16,723	$25.09 average	420K	52%	Form 4
Mar 6, 2025	Jenny Herman SVP & Controller	Sold10b5-1 plan	666	$21.11	14K	2.4%	Form 4
Mar 3, 2025	Geoffrey Craig Porges EVP & CFO	Sold10b5-1 plan	5,491	$21.76	119K	17%	Form 4
Feb 18, 2025	Yvonne Tran EVP, CLO & Cpo	Sold10b5-1 plan	3,902	$28.00	109K	26%	Form 4
Feb 11, 2025	Kenneth Patrick Lorton EVP, CTO & COO, Software	Sold10b5-1 plan	985	$24.43	24K	2.3%	Form 4
Feb 11, 2025	Jenny Herman SVP & Controller	Sold10b5-1 plan	859	$24.43	21K	4.5%	Form 4
Feb 11, 2025	Yvonne Tran EVP, CLO & Cpo	Sold10b5-1 plan	828	$24.43	20K	6.9%	Form 4
Feb 10, 2025	Robert Lorne Abel See Remarks	Sold10b5-1 plan	1,225	$25.99	32K	13%	Form 4

Sep 1710b5-1 plan
Karen Akinsanya
See Remarks · sold 31,599 at avg $29.37
928K
31% of stake
Jul 1610b5-1 plan
Rachit Jain
EVP & CFO · sold 875 at $15.60
14K
1.7% of stake
Apr 16 – 1710b5-1 plan
Ramy Farid
President & CEO · sold 86,000 at avg $12.27
$1.06M
18% of stake
Apr 1610b5-1 plan
Rachit Jain
EVP & CFO · sold 844 at $12.75
11K
1.6% of stake
Mar 5 – 610b5-1 plan
Jenny Herman
CAO · sold 1,383 at avg $12.85
18K
3.8% of stake
Mar 510b5-1 plan
Rachit Jain
EVP & CFO · sold 1,631 at $12.90
21K
3.0% of stake
Mar 510b5-1 plan
Yvonne Tran
EVP, CLO & Cpo · sold 1,094 at $12.90
14K
2.0% of stake
Mar 510b5-1 plan
Kenneth Patrick Lorton
EVP, CTO & COO, Software · sold 1,222 at $12.90
16K
1.4% of stake
Mar 510b5-1 plan
Ramy Farid
President & CEO · sold 3,661 at $12.91
47K
1.1% of stake
Mar 510b5-1 plan
Karen Akinsanya
See Remarks · sold 1,366 at $12.90
18K
1.9% of stake
Mar 410b5-1 plan
Robert Lorne Abel
See Remarks · sold 1,300 at $12.81
17K
2.3% of stake
Mar 210b5-1 plan
Ramy Farid
President & CEO · sold 5,560 at $11.90
66K
1.6% of stake
Mar 210b5-1 plan
Karen Akinsanya
See Remarks · sold 2,206 at $11.99
26K
3.0% of stake
Feb 1010b5-1 plan
Jenny Herman
CAO · sold 752 at $13.79
10K
2.7% of stake
Feb 1010b5-1 plan
Yvonne Tran
EVP, CLO & Cpo · sold 776 at $13.80
11K
3.3% of stake
Feb 1010b5-1 plan
Kenneth Patrick Lorton
EVP, CTO & COO, Software · sold 925 at $13.73
13K
1.7% of stake
Feb 910b5-1 plan
Robert Lorne Abel
See Remarks · sold 1,230 at $13.51
17K
6.0% of stake
Oct 16, 202510b5-1 plan
Margaret Dugan
Chief Medical Officer · sold 1,395 at $21.07
29K
5.4% of stake
Apr 14, 202510b5-1 plan
Karen Akinsanya
President of R&D, Therapeutics · sold 16,723 at avg $25.09
420K
52% of stake
Mar 6, 202510b5-1 plan
Jenny Herman
SVP & Controller · sold 666 at $21.11
14K
2.4% of stake
Mar 3, 202510b5-1 plan
Geoffrey Craig Porges
EVP & CFO · sold 5,491 at $21.76
119K
17% of stake
Feb 18, 202510b5-1 plan
Yvonne Tran
EVP, CLO & Cpo · sold 3,902 at $28.00
109K
26% of stake
Feb 11, 202510b5-1 plan
Kenneth Patrick Lorton
EVP, CTO & COO, Software · sold 985 at $24.43
24K
2.3% of stake
Feb 11, 202510b5-1 plan
Jenny Herman
SVP & Controller · sold 859 at $24.43
21K
4.5% of stake
Feb 11, 202510b5-1 plan
Yvonne Tran
EVP, CLO & Cpo · sold 828 at $24.43
20K
6.9% of stake
Feb 10, 202510b5-1 plan
Robert Lorne Abel
See Remarks · sold 1,225 at $25.99
32K
13% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SDGR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SDGR

CompareIntrinsic value

SNDXSyndax Pharmaceuticals Inc.

$10.45-26.87%0

HROWHarrow Inc.

$28.75+0.74%46

LGNDLigand Pharmaceuticals Inc.

$316.13+0.83%36

RIGLRigel Pharmaceuticals, Inc.

$51.29+4.97%87

RYTMRhythm Pharmaceuticals Inc.

$110.68+28.04%40

PHATPhathom Pharmaceuticals Inc.

$5.68-1.05%10

RCUSArcus Biosciences Inc.

$19.31+2.12%10

ANABAnaptysBio Inc.

$47.51-0.46%20

Held by ETFs

SDGR is in 50 US ETFs. The largest of them, with SDGR's weight in each:

Spot a number that looks wrong? Check it in SDGR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SDGR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.